Stockreport

UroGen Pharma Reports Second Quarter 2019 Financial Results and Recent Corporate Developments

UroGen Pharma Ltd. - Ordinary Shares  (URGN) 
Last urogen pharma ltd. - ordinary shares earnings: 3/2 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.urogen.com
PDF UGN-101 Rolling NDA Submission on Track for Q4 2019 with Planned Launch in 1H 2020Final Topline UGN-101 Phase 3 Data from OLYMPUS Trial to be Announced in Q3 2019Company [Read more]